Core Viewpoint - ST Jinfeng officially entered judicial reorganization on October 21, becoming the seventh A-share company to obtain a "reorganization road sign" this year. Despite the cash injection of 526 million yuan from Shiyao Group and 122 million yuan from German state-owned enterprises, the company still faces significant operational, financial, governance, and integration risks [1] Financial Challenges - ST Jinfeng's ability to continue operations is in doubt, with a net profit loss of 76.12 million yuan and a high debt-to-asset ratio of 101.61%. The company has incurred cumulative losses of nearly 2.4 billion yuan since 2019, leading to liquidity crises and bankruptcy pre-reorganization applications [2] Uncertainties in Reorganization - The reorganization process faces multiple challenges, including the difficulty of implementing the reorganization plan submitted by Shiyao, the need for creditor support, and the complexities of asset separation and injection. Additionally, the recovery of core assets and the integration of new management may impact operational stability [3] Business Decline and Product Risks - ST Jinfeng's main business has significantly declined, with injection drug revenue dropping over 70% since its core products were excluded from the national medical insurance catalog in 2019. The company has not established alternative product lines, leaving it vulnerable to market pressures [4] Asset Disposal and Related Party Transactions - Prior to reorganization, ST Jinfeng's subsidiary, Dalian Dezhe, engaged in profit distribution, capital reduction, and asset repurchase, raising concerns about the fairness of these transactions and potential harm to the overall interests of the listed company [5] Conclusion on Reorganization - Obtaining the "reorganization road sign" is just the beginning of ST Jinfeng's challenges. While the entry of Shiyao Group brings capital and resources, the company must address business recovery, debt resolution, governance integration, and market trust rebuilding to achieve a true turnaround [6]